A 34-year-old man presented with an out-of-hospital cardiac arrest shortly after dermal exposure to tetramethylammonium hydroxide (TMAH). The patient was accidentally exposed to 2.38% TMAH despite the use of personal protective equipment and was referred to our emergency department one hour after the exposure. He was resuscitated using advanced cardiac life support and intensive care. However, he remained unconscious despite target temperature management. Second-degree chemical burns were found on 10% of his total body surface area. Brain magnetic resonance imaging showed severe anoxic-ischemic encephalopathy involving bilateral supratentorial grey matter. TMAH was detected in the patient’ s blood and urine. To the best of our knowledge, this is the first report of the identification of TMAH in the serum and urine after exposure to the agent. Previous cases of cardiac arrest reported were due to exposure to high concentrations of 25% TMAH. We postulate that even low concentrations of TMAH could be absorbed rapidly after dermal exposure and can have fatal consequences.

Health centers provided intensive health care services for local residents according to changes in the times and environment. Public health centers were given various roles such as medical treatment, administration, and service, and the demand for functional reorganization has emerged. We analyzed the literature on the functional restructuring of public health care institutions. In addition, the current status of medical services, which is the main function of institutions, will be analyzed through health insurance statistical data, and detailed contents will be analyzed according to regional types and income levels. As a result of the analysis of medical services at institutions, the total number of patients was 2,238,000, and the number of visits was 11,806 times. Total medical expenses were 169.6 billion won, of which 132 billion won was found to be benefit. When analyzing the number of patients per institution, public health centers had the largest number of 4,326, and the share of benefit was also the highest at public health centers. It should focus on the function of providing local health and medical services related to health promotion and disease prevention in the community. This functional reorganization of public health centers can contribute to forming cooperative relationships with private medical institutions in the local community. For this, first, to establish the role, essential functions for public health centers for preventive health management are established. Secondly, regular manpower expansion and flexible manpower management are required in the human resources sector. Finally, in the organizational sector, it is necessary to establish a step-by-step organizational system according to environmental changes.

Emerging infectious diseases have risen sharply due to population growth, urbanization, travel, trade, and environmental changes, with outbreaks like severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019 highlighting the global need for effective surveillance systems. Various infectious disease surveillance systems are applied depending on the surveillance objectives, target populations, and geographical scope. While Korea has a robust surveillance system, challenges remain in integrating data, enhancing coordination, and improving response efficiency. This article reviews the types and roles of infectious disease surveillance systems through a literature review and proposes strategies for improving Korea’s surveillance system by comparing it with those of other countries, including the World Health Organization (WHO). To strengthen Korea’s surveillance framework, a comprehensive strategy should be implemented to interconnect multiple surveillance mechanisms and enhance real-time data sharing. A centralized data platform must integrate these systems, leveraging artificial intelligence and big data analytics for faster outbreak analysis. International collaboration through data-sharing networks with the WHO, European Center for Disease Prevention and Control, and U.S Centers for Disease Control and Prevention is essential, along with standardized reporting formats to improve interoperability.

Emerging infectious diseases have risen sharply due to population growth, urbanization, travel, trade, and environmental changes, with outbreaks like severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019 highlighting the global need for effective surveillance systems. Various infectious disease surveillance systems are applied depending on the surveillance objectives, target populations, and geographical scope. While Korea has a robust surveillance system, challenges remain in integrating data, enhancing coordination, and improving response efficiency. This article reviews the types and roles of infectious disease surveillance systems through a literature review and proposes strategies for improving Korea’s surveillance system by comparing it with those of other countries, including the World Health Organization (WHO). To strengthen Korea’s surveillance framework, a comprehensive strategy should be implemented to interconnect multiple surveillance mechanisms and enhance real-time data sharing. A centralized data platform must integrate these systems, leveraging artificial intelligence and big data analytics for faster outbreak analysis. International collaboration through data-sharing networks with the WHO, European Center for Disease Prevention and Control, and U.S Centers for Disease Control and Prevention is essential, along with standardized reporting formats to improve interoperability.

Emerging infectious diseases have risen sharply due to population growth, urbanization, travel, trade, and environmental changes, with outbreaks like severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019 highlighting the global need for effective surveillance systems. Various infectious disease surveillance systems are applied depending on the surveillance objectives, target populations, and geographical scope. While Korea has a robust surveillance system, challenges remain in integrating data, enhancing coordination, and improving response efficiency. This article reviews the types and roles of infectious disease surveillance systems through a literature review and proposes strategies for improving Korea’s surveillance system by comparing it with those of other countries, including the World Health Organization (WHO). To strengthen Korea’s surveillance framework, a comprehensive strategy should be implemented to interconnect multiple surveillance mechanisms and enhance real-time data sharing. A centralized data platform must integrate these systems, leveraging artificial intelligence and big data analytics for faster outbreak analysis. International collaboration through data-sharing networks with the WHO, European Center for Disease Prevention and Control, and U.S Centers for Disease Control and Prevention is essential, along with standardized reporting formats to improve interoperability.

Emerging infectious diseases have risen sharply due to population growth, urbanization, travel, trade, and environmental changes, with outbreaks like severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019 highlighting the global need for effective surveillance systems. Various infectious disease surveillance systems are applied depending on the surveillance objectives, target populations, and geographical scope. While Korea has a robust surveillance system, challenges remain in integrating data, enhancing coordination, and improving response efficiency. This article reviews the types and roles of infectious disease surveillance systems through a literature review and proposes strategies for improving Korea’s surveillance system by comparing it with those of other countries, including the World Health Organization (WHO). To strengthen Korea’s surveillance framework, a comprehensive strategy should be implemented to interconnect multiple surveillance mechanisms and enhance real-time data sharing. A centralized data platform must integrate these systems, leveraging artificial intelligence and big data analytics for faster outbreak analysis. International collaboration through data-sharing networks with the WHO, European Center for Disease Prevention and Control, and U.S Centers for Disease Control and Prevention is essential, along with standardized reporting formats to improve interoperability.

OBJECTIVE: compare quality of life (QoL) and sexual functioning between sexually active ovarian cancer survivors and healthy women. METHODS: A cross-sectional study was performed in 103 successfully treated ovarian cancer survivors and 220 healthy women. All women had engaged in sexual activity within the previous 3 months, and ovarian cancer survivors were under surveillance after primary treatment without evidence of disease. QoL and sexual functioning were assessed using three questionnaires; the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), Ovarian Cancer Module (EORTC QLQ-OV28), and the Female Sexual Function Index (FSFI). Propensity score matching was used to adjust covariates between the ovarian cancer survivor and healthy women groups. In total, 73 ovarian cancer survivors and 73 healthy women were compared. RESULTS: Poorer social functioning (mean, 82.4 vs. 90.9; p=0.010) and more financial difficulties (mean, 16.4 vs. 7.8; p=0.019) were observed among ovarian cancer survivors than among healthy women. Sexuality, both in terms of desire, arousal, lubrication, orgasm, satisfaction, and pain and in terms of interest in sex, sexual activity, and enjoyment of sex (EORTC QLQ-OV28) were similar between the groups. However, vaginal dryness was more problematic in ovarian cancer survivors, with borderline statistical significance (p=0.081). CONCLUSION: Sexuality was not impaired in ovarian cancer survivors who were without evidence of disease after primary treatment and having sexual activities, compared with healthy women, whereas social functioning and financial status did deteriorate. Prospective cohort studies are needed.
Adult ; Case-Control Studies ; Cross-Sectional Studies ; Female ; Health ; Humans ; Middle Aged ; *Ovarian Neoplasms/epidemiology/psychology/rehabilitation ; *Quality of Life/psychology ; Sexual Behavior/*physiology/psychology ; *Sexuality/physiology/psychology ; Socioeconomic Factors ; Surveys and Questionnaires ; *Survivors/psychology/statistics & numerical data

Clopidogrel is an antiplatelet agent prescribed widely to prevent stent thrombosis after coronary or peripheral vascular interventions and for stroke prophylaxis. The side effects of this drug include gastrointestinal symptoms, such as nausea, abdominal pain, vomiting, and bleeding. Thrombotic thrombocytopenia purpura (TTP) is a rare complication of this drug. Here, we report a case of clopidogrel-associated TTP in a patient with cerebral infarction. To our knowledge, it is first reported case of clopidogrel-associated TTP in Korea.
Abdominal Pain ; Cerebral Infarction* ; Hemorrhage ; Humans ; Korea ; Nausea ; Purpura ; Purpura, Thrombotic Thrombocytopenic* ; Stents ; Stroke ; Thrombocytopenia ; Thrombosis ; Vomiting

Clopidogrel is an antiplatelet agent prescribed widely to prevent stent thrombosis after coronary or peripheral vascular interventions and for stroke prophylaxis. The side effects of this drug include gastrointestinal symptoms, such as nausea, abdominal pain, vomiting, and bleeding. Thrombotic thrombocytopenia purpura (TTP) is a rare complication of this drug. Here, we report a case of clopidogrel-associated TTP in a patient with cerebral infarction. To our knowledge, it is first reported case of clopidogrel-associated TTP in Korea.
Abdominal Pain ; Cerebral Infarction* ; Hemorrhage ; Humans ; Korea ; Nausea ; Purpura ; Purpura, Thrombotic Thrombocytopenic* ; Stents ; Stroke ; Thrombocytopenia ; Thrombosis ; Vomiting

PURPOSE: To report on 2 cases of Eales' disease that were successfully regressed with laser photocoagulation and intravitreal bevacizumab (Avastin; Genetech, Inc, San Francisco, California, USA) injection. CASE SUMMARY: Two male patients (30 years and, 40 years of age,) with a history of recurrent vitreous hemorrhage were diagnosed with Eales' disease. The 2 patients had peripheral retina neovascularization and active phlebitis in fundus fluorescein angiography. No other findings were observed in their eyes in the general examination. Scatter laser photocoagulation and intravitreal bevacizumab injection were performed. After 1 month follow-up, neovascularization completely regressed. There was no complication or recurrent vitreous hemorrhage at the 1 year follow up. CONCLUSIONS: Intravitreal bevacizumab injection, as combination treatment of laser photocoagulation, may be helpful in the regression of neovascularization due to Eales' disease.
Antibodies, Monoclonal, Humanized ; California ; Eye ; Fluorescein Angiography ; Follow-Up Studies ; Humans ; Light Coagulation ; Male ; Phlebitis ; Retina ; San Francisco ; Vitreous Hemorrhage ; Bevacizumab